Gerard Coquerel

USPTO Granted Patents = 18 (Patent Applications = 3)

CIPO Patents = 11 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 51(Granted Patents)

Location History:

Mont Saint Aignan, FR (2013 - 2014)
Boos, FR (2001 - 2024)

Company Filing History:

6 out of 290

Les Laboratoires Servier

Takeda Pharmaceutical Company Limited

patents

5. 1 out of 1

Organisation De Synthese Mondiale Orsymonde

patent

6. 1 out of 23

Viropharma Incorporated

Les Laboratories Servier

patents

9. 1 out of 3

Produits Chimiques Auxiliaires Et De Synthese

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060382 - Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole (2024-08-13),

2. 11130777 - Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole (2021-09-28),

3. 9340497 - Method for the preparation of (3S,3S') 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) (2016-05-17),

4. 9255898 - Method of measuring scattering of X-rays, its applications and implementation device (2016-02-09),

5. 8907106 - Process for the resolution of enantiomers by preferential evaporative crystallization (2014-12-09),

6. 8592601 - Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer (2013-11-26),

7. 8546344 - Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole (2013-10-01),

8. 8252957 - Process for obtaining the crystalline form V of agomelatine (2012-08-28),

9. 8067639 - Crystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2011-11-29),

10. 7939566 - Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2011-05-10),

11. 7910625 - Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2011-03-22),

12. 7649020 - Modafinil polymorphic forms (2010-01-19),

13. 7645905 - Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2010-01-12),

14. 7635721 - Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2009-12-22),

15. 7405323 - Modafinil polymorphic forms (2008-07-29),

Title: Gerard Coquerel: Innovator in Pharmaceutical Sciences

Introduction

Gerard Coquerel is a distinguished inventor based in Boos, France, with an impressive portfolio of 18 patents. His contributions to pharmaceutical sciences, particularly in the development of novel crystalline phases, have made significant impacts in medical therapy.

Latest Patents

Coquerel's latest patents focus on the pharmaceutical compound Maribavir, specifically pertaining to crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-(β-L-ribofuranosyl)-1H-benzimidazole. These inventions detail innovative compositions that enhance the efficacy of this compound in medical treatments. The patents underscore the importance of crystalline forms in maximizing therapeutic benefits and provide valuable insights for medicinal research and application.

Career Highlights

Throughout his career, Coquerel has been associated with notable organizations, including Les Laboratoires Servier and Université de Rouen. His work at these institutions has allowed him to conduct extensive research and development, leading to advancements in pharmaceutical formulation and therapeutic applications.

Collaborations

Coquerel has collaborated with several esteemed colleagues in his field, including Julie Linol and Jean-Claude J. Souvie. These collaborations have fostered an environment of shared knowledge and innovation, driving the advancement of their collective research efforts in pharmaceutical sciences.

Conclusion

Gerard Coquerel's dedication to innovation within the pharmaceutical sector is evident through his numerous patents and collaborations. His work continues to influence medical therapy, showcasing the essential role inventors play in the advancement of healthcare solutions. As research and development progress, Coquerel remains a key figure in the ongoing exploration of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents pending:

Please report any incorrect information to support@idiyas.com

11 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.